High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome - Chretien, Anne-Sophie; Devillier, Raynier; Granjeaud, Samuel; Cordier, Charlotte; Demerle, Clemence; Salem, Nassim; Wlosik, Julia; Orlanducci, Florence; Gorvel, Laurent; Fattori, Stephane; Hospital, Marie-Anne; Pakradouni, Jihane; et al. (Proceedings of the National Academy of Sciences - PNAS, 2021)
Keywords: Accumulation; Acute myeloid leukemia; Anticancer properties; Biological Sciences; CD16 antigen; CD226 antigen; CD56 antigen; Cell activation; Clinical outcomes; Cytometry; Dimensional analysis; HIV; Human immunodeficiency virus; Innate immunity; Leukemia; Life Sciences; Medical Sciences; Multivariate analysis; Myeloid leukemia; Natural killer cells; NKG2 antigen; Peripheral blood; Phenotyping; Receptors; Subgroups; Survival; AML; natural killer cells; CD16; NK cells; mass cytometry; CD56; CD56−CD16+ NK cells